Work

Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or colorectal cancer (CRC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.4_suppl.tps725

Authors: J. Randolph Hecht, Arlene Chan, Miguel Martin, Nicolas Mach, Sara A. Hurvitz, Sylvie Rottey, Uwe Pelzer, Chunxu Liu, Emily Chan

Institutions: University of California, Los Angeles, Curtin University, Hospital General Universitario Gregorio Marañón, University Hospital of Geneva, Fondation Dr Henri Dubois-Ferrière Dinu Lipatti, Ghent University Hospital, Charité – Universitätsmedizin Berlin, Amgen (United States)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912376565

Cites:

Cited by: 3

Related to: 10